HIV Citation List: November 8 - November 21, 2013

PubMed citations

1. Contribution of Oligomerization to the anti-HIV-1 Properties of SAMHD1.Brandariz-Nunez, A., J.C. Valle-Casuso, T.E. White, L. Nguyen, A. Bhattacharya, Z. Wang, B. Demeler, S. Amie, C. Knowlton, B. Kim, D.N. Ivanov, and F. Diaz-Griffero. Retrovirology, 2013. 10(1): p. 131. PMID[24219908].

[PubMed]. HIV_1108-112113.

2. Evaluation of PD 404,182 as an anti-HIV and anti-HSV Microbicide.Chamoun-Emanuelli, A.M., M. Bobardt, B. Moncla, M.K. Mankowski, R.G. Ptak, P. Gallay, and Z. Chen. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24217696].

[PubMed]. HIV_1108-112113.

3. Structure-based Design of an RNA-binding p-Terphenylene Scaffold That Inhibits HIV-1 Rev Protein Function. Gonzalez-Bulnes, L., I. Ibanez, L.M. Bedoya, M. Beltran, S. Catalan, J. Alcami, S. Fustero, and J. Gallego. Angewandte Chemie, 2013. [Epub ahead of print]. PMID[24214163].

[PubMed]. HIV_1108-112113.

4. Novel Neuroprotective GSK-3beta Inhibitor Restricts Tat-mediated HIV-1 Replication.Guendel, I., S. Iordanskiy, R. Van Duyne, K. Kehn-Hall, M. Saifuddin, R. Das, E. Jaworski, G.C. Sampey, S. Senina, L. Shultz, A. Narayanan, H. Chen, B. Lepene, C. Zeng, and F. Kashanchi. Journal of Virology, 2013. [Epub ahead of print]. PMID[24227837].

[PubMed]. HIV_1108-112113.

5. IFI16 Senses DNA Forms of the Lentiviral Replication Cycle and Controls HIV-1 Replication.Jakobsen, M.R., R.O. Bak, A. Andersen, R.K. Berg, S.B. Jensen, T. Jin, A. Laustsen, K. Hansen, L. Ostergaard, K.A. Fitzgerald, T.S. Xiao, J.G. Mikkelsen, T.H. Mogensen, and S.R. Paludan. Proceedings of the National Academy of Sciences of the United States of America, 2013. [Epub ahead of print]. PMID[24154727].

[PubMed]. HIV_1108-112113.

6. Design and Synthesis of P1-P3 Macrocyclic Tertiary-alcohol-comprising HIV-1 Protease Inhibitors. Joshi, A., J.B. Veron, J. Unge, A. Rosenquist, H. Wallberg, B. Samuelsson, A. Hallberg, and M. Larhed. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24160253].

[PubMed]. HIV_1108-112113.

7. Synthesis of a C-glycoside Analogue of Beta-galactosyl Ceramide, a Potential HIV-1 Entry Inhibitor. Thota, V.N., M. Brahmaiah, and S.S. Kulkarni. The Journal of Organic Chemistry, 2013. [Epub ahead of print]. PMID[24199837].

[PubMed]. HIV_1108-112113.

8. Discovery of a Diaminoquinoxaline Benzenesulfonamide Antagonist of HIV-1 Nef Function Using a Yeast-based Phenotypic Screen. Trible, R.P., P. Narute, L.A. Emert-Sedlak, J.J. Alvarado, K. Atkins, L. Thomas, T. Kodama, N. Yanamala, V. Korotchenko, B.W. Day, G. Thomas, and T.E. Smithgall. Retrovirology, 2013. 10(1): p. 135. PMID[24229420].

[PubMed]. HIV_1108-112113.

9. Highly Enantioselective Decarboxylative Mannich Reaction of Malonic acid Half Oxyesters with Cyclic Trifluoromethyl Ketimines: Synthesis of Beta-amino Esters and anti-HIV Drug DPC 083. Yuan, H.N., S. Li, J. Nie, Y. Zheng, and J.A. Ma. Chemistry, 2013. 19(47): p. 15856-15860. PMID[24150893].

[PubMed]. HIV_1108-112113.

10. Dual-acting Stapled Peptides Target Both HIV-1 Entry and Assembly.Zhang, H., F. Curreli, A.A. Waheed, P.Y. Mercredi, M. Mehta, P. Bhargava, D. Scacalossi, X. Tong, S. Lee, A. Cooper, M.F. Summers, E.O. Freed, and A.K. Debnath. Retrovirology, 2013. 10(1): p. 136. PMID[24237936].

[PubMed]. HIV_1108-112113.

11. A Novel Ribonuclease with Antiproliferative Activity toward Leukemia and Lymphoma Cells and HIV-1 Reverse Transcriptase Inhibitory Activity from the Mushroom, Hohenbuehelia serotina. Zhang, R., L. Zhao, H. Wang, and T.B. Ng. International Journal of Molecular Medicine, 2013. [Epub ahead of print]. PMID[24220107].

[PubMed]. HIV_1108-112113.

12. Characterization of VRC01, a Potent and Broadly Neutralizing anti-HIV mAb, Produced in Transiently and Stably Transformed Tobacco. Teh, A.Y., D. Maresch, K. Klein, and J.K. Ma. Plant Biotechnology Journal, 2013. [Epub ahead of print]. PMID[24256218].

[PubMed]. HIV_1108-112113.

ISI Web of Knowledge Citations

13. Characterization of Human anti-V3 Monoclonal Antibody 904 Isolated from an Indian Clade C Human Immunodeficiency Virus Type-1 (HIV-1) Infected Donor.Andrabi, R., M. Makhdoomi, and K. Luthra. Retrovirology, 2013. 10: p. S24-S25. ISI[000326099100076].

[WOS]. HIV_1108-112113.

14. Human beta-Defensin 2 and 3 Inhibit HIV in Primary Macrophages: Implications for HIV Infection of the CNS. Bharucha, J.P., M. Lafferty, O. Latinovic, W.Y. Lu, S. Gartner, and A. Garzino-Demo. Journal of Neurovirology, 2013. 19: p. S13-S14. ISI[000325777200028].

[WOS]. HIV_1108-112113.

15. Design, Synthesis and Biological Evaluation of N-2,N-4-Disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine Derivatives as HIV-1 NNRTIs.Chen, W.M., P. Zhan, E. De Clercq, C. Pannecouque, J. Balzarini, X. Jiang, and X.Y. Liu. Bioorganic & Medicinal Chemistry, 2013. 21(22): p. 7091-7100. ISI[000325759800025].

[WOS]. HIV_1108-112113.

16. 2-Hydroxyisoquinoline-1,3(2H, 4H)diones (HQDs), Novel Inhibitors of the HIV Integrase Catalytic Activity with a High Barrier to Resistance.Christ, F., J. Demeulemeester, B. Desimmie, V. Suchaud, O. Taltynov, C. Lion, F. Bailly, S. Strelkov, P. Cotelle, and Z. Debyser. Retrovirology, 2013. 10: p. S15-S15. ISI[000326099100048].

[WOS]. HIV_1108-112113.

17. LEDGINs, a Novel Class of Antivirals Targeting HIV Integrase During Integration and Assembly. Debyser, Z. Retrovirology, 2013. 10: p. S9-S9. ISI[000326099100032].

[WOS]. HIV_1108-112113.

18. Novel Neuroprotective GSK-3beta Inhibitor Restricts Tat-mediated HIV-1 Replication. Guendel, I., R. Van Duyne, K. Kehn-Hall, M. Saifuddin, R. Das, E. Jaworski, G. Sampey, S. Senina, L. Shultz, A. Narayanan, H. Chen, S. Iordanskiy, B. Lepene, C. Zeng, and F. Kashanchi. Journal of Neurovirology, 2013. 19: p. S35-S35. ISI[000325777200074].

[WOS]. HIV_1108-112113.

19. Anti-HIV-1 Peptide Derivatives Based on the HIV-1 Co-receptor CXCR4.Hashimoto, C., W. Nomura, T. Narumi, M. Fujino, H. Tsutsumi, M. Haseyama, N. Yamamoto, T. Murakami, and H. Tamamura. ChemMedChem, 2013. 8(10): p. 1668-1672. ISI[000325137800016].

[WOS]. HIV_1108-112113.

20. Linking Genotype to Phenotype on Beads: High Throughput Selection of Peptides with Biological Function. Huang, L.C., X.Y. Pan, H.B. Yang, L.K.D. Wan, G. Stewart-Jones, L. Dorrell, and G. Ogg. Scientific Reports, 2013. 3. ISI[000325973900001].

[WOS]. HIV_1108-112113.

21. Alkali Carbonate Effects on N-(2-Hydroxyethyl)urea Cyclization: Application to a 2-Imidazolidinone Scale-up. Kaldor, I., T. Spitzer, M.S. Duan, W.M. Kazmierski, and E.E. Boros. Journal of Heterocyclic Chemistry, 2013. 50(4): p. 863-867. ISI[000325924800019].

[WOS]. HIV_1108-112113.

22. Infection by CXCR4-tropic Human Immunodeficiency Virus Type 1 (HIV-1) is Inhibited by the Cationic Cell Penetrating Peptide Derived from HIV-1 Tat.Keogan, S., S. Passic, B. Wigdahl, and F.C. Krebs. Journal of Neurovirology, 2013. 19: p. S42-S42. ISI[000325777200089].

[WOS]. HIV_1108-112113.

23. Efficient Electrophilic Fluorination for the Synthesis of Novel 2'-Fluoro-3'-methyl-5'-deoxyphosphonic acid Apiosyl Nucleoside Analogues.Kim, K.M. and J.H. Hong. Nucleosides Nucleotides & Nucleic Acids, 2013. 32(10): p. 555-570. ISI[000325601600002].

[WOS]. HIV_1108-112113.

24. Membrane-associated RING-CH (March) 8 Protein Inhibits HIV-1 Infection. Koyama, T., T. Tada, H. Fujita, and K. Tokunaga. Retrovirology, 2013. 10: p. S32-S32. ISI[000326099100099].

[WOS]. HIV_1108-112113.

25. Iron Depletion by Iron Chelators or Ferroportin Inhibits HIV-1 through the Induction of HIF1a, P21 and IKBa and the Inhibition of CDK9 and CDK2.Kumari, N., D. Kovalsky, D. Breuer, X.M. Niu, and S. Nekhai. Retrovirology, 2013. 10: p. S27-S27. ISI[000326099100084].

[WOS]. HIV_1108-112113.

26. The Interferon-induced MxB Protein Inhibits an Early Step of HIV-1 Infection. Liu, Z.L., Q.H. Pan, S.L. Ding, J. Qian, F.W. Xu, J.M. Zhou, S. Cen, F. Guo, and C. Liang. Retrovirology, 2013. 10: p. S23-S24. ISI[000326099100073].

[WOS]. HIV_1108-112113.

27. Identification of Myxobacteria-derived HIV Inhibitors by a High-throughput Two-step Infectivity Assay. Martinez, J.P., B. Hinkelmann, E. Fleta-Soriano, H. Steinmetz, R. Jansen, J. Diez, R. Frank, F. Sasse, and A. Meyerhans. Microbial Cell Factories, 2013. 12 (1): p. 85. ISI[000325795700001].

[WOS]. HIV_1108-112113.

28. The Novel Antiretroviral Compound, FX101, Reduces Virus and Provirus Burden in Cats Chronically Infected with FIV LU Infected with FIV.Meeker, R., L. Hudson, and H. Kay. Journal of Neurovirology, 2013. 19: p. S57-S58. ISI[000325777200121].

[WOS]. HIV_1108-112113.

29. Toward the Discovery of Inhibitors of Babesipain-1, a Babesia bigemina Cysteine Protease: In Vitro Evaluation, Homology Modeling and Molecular Docking Studies. Perez, B., S. Antunes, L.M. Goncalves, A. Domingos, J.R.B. Gomes, P. Gomes, and C. Teixeira. Journal of Computer-aided Molecular Design, 2013. 27(9): p. 823-835. ISI[000326045600006].

[WOS]. HIV_1108-112113.

30. Targeting CCL2 Inhibits Viral DNA Accumulation and Induces APOBEC3A Expression in HIV-1 Infected Primary Human Macrophages.Sabbatucci, M., A. Mallano, C. Purificato, D.A. Covino, M. Federico, S. Vella, S. Gessani, M. Andreotti, and L. Fantuzzi. Retrovirology, 2013. 10: p. S18-S19. ISI[000326099100058].

[WOS]. HIV_1108-112113.

31. Phenylethanoids from the Roots of Codonopsis cordifolioidea and Their Anti HIV-1 Activities. Shen, Y.Q., J.H. Yao, L.D. Shu, L.Y. Yang, X.M. Gao, and Q.F. Hu. Asian Journal of Chemistry, 2013. 25(14): p. 7888-7890. ISI[000325096400054].

[WOS]. HIV_1108-112113.

32. Synthesis of 4'-C-Alkylated-5-iodo-2'-deoxypyrimidine Nucleosides.Strittmatter, T., J. Aschenbrenner, N. Hardt, and A. Marx. Arkivoc, 2013: p. 46-59. ISI[000324460900006].

[WOS]. HIV_1108-112113.

33. A Novel Synthesis of Antiviral Nucleoside Phosphoramidate and Thiophosphoramidate Prodrugs Via Nucleoside H-phosphonamidates.Sun, Q., X.J. Li, S.S. Gong, G. Liu, L. Shen, and L. Peng. Nucleosides Nucleotides & Nucleic Acids, 2013. 32(11): p. 617-638. ISI[000325786800003].

[WOS]. HIV_1108-112113.

34. ZnO-mediated Regioselective C-Arylsulfonylation of Indoles: A Facile Solvent-free Synthesis of 2- and 3-Sulfonylindoles and Preliminary Evaluation of Their Activity against Drug-resistant Mutant HIV-1 Reverse Transcriptases (RTs).Tocco, G., M. Begala, F. Esposito, P. Caboni, V. Cannas, and E. Tramontano. Tetrahedron Letters, 2013. 54(46): p. 6237-6241. ISI[000326009300022].

[WOS]. HIV_1108-112113.

35. Modular Assembly of Dimeric HIV Fusion Inhibitor Peptides with Enhanced Antiviral Potency. Xiao, J.P. and T.J. Tolbert. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6046-6051. ISI[000325760300003].

[WOS]. HIV_1108-112113.

36. Role of the K101E Substitution in HIV-1 Reverse Transcriptase in Resistance to Rilpivirine and Other Nonnucleoside Reverse Transcriptase Inhibitors. Xu, H.T., S.P. Colby-Germinario, W. Huang, M. Oliveira, Y.S. Han, Y.D. Quan, C.J. Petropoulos, and M.A. Wainberg. Antimicrobial Agents and Chemotherapy, 2013. 57(11): p. 5649-5657. ISI[000325764000057].

[WOS]. HIV_1108-112113.

37. Design and Synthesis of Novel Pyrimidone Analogues as HIV-1 Integrase Inhibitors. Yu, S., T.W. Sanchez, Y. Liu, Y.Z. Yin, N. Neamati, and G.S. Zhao. Bioorganic & Medicinal Chemistry Letters, 2013. 23(22): p. 6134-6137. ISI[000325760300020].

[WOS]. HIV_1108-112113.